Feedback / Questions
Imfinzi (durvalumab) - AstraZeneca
monalizumab (IPH2201) - AstraZeneca, Innate
oleclumab (MEDI9447) - AstraZeneca
http://clinicaltrials.gov/ct2/show/NCT03801902
Sep 23, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next